Effects of activated protein C on the mesenteric microcirculation and cytokine release during experimental endotoxemiaLEHMANN, Christian; SCHEIBE, Ricardo; PAVLOVIC, Dragan et al.Canadian journal of anaesthesia. 2008, Vol 55, Num 3, pp 155-162, issn 0832-610X, 8 p.Article

Effects of recombinant human activated protein C on the coagulation system : a study with rotational thromboelastometryNILSSON, C. U; HELLKVIST, P. D; ENGSTRÖM, M et al.Acta anaesthesiologica scandinavica. 2008, Vol 52, Num 9, pp 1246-1249, issn 0001-5172, 4 p.Article

Factor Va, bound to microparticles released during platelet storage, is resistant to inactivation by activated protein CMAGDELEYNS, Elke J. P; KEUREN, Jeffrey F. W; CURVERS, Joyce et al.Transfusion (Philadelphia, PA). 2007, Vol 47, Num 10, pp 1880-1888, issn 0041-1132, 9 p.Article

Factor V Cambridge mutation and activated protein C resistance assaysLE CAM-DUCHEZ, Véronique; CHRETIEN, Marie-Hélène; SAUEIER-VEBER, Pascale et al.Thrombosis and haemostasis. 2006, Vol 95, Num 3, pp 581-583, issn 0340-6245, 3 p.Article

Resistance to activated protein C in healthy women taking oral contraceptivesOLIVIERI, O; FRISO, S; CORROCHER, R et al.British journal of haematology. 1995, Vol 91, Num 2, pp 465-470, issn 0007-1048Article

Contribution à l'étude des effets biologiques de la protéine C activée d'origine humaine = Contribution to the study of biological effects of human activated protein CMarque, Suzanne; Trouve, Renaud.1992, 220 p.Thesis

A novel factor V mutation causes a normal activated protein C ratio despite the presence of a heterozygous F5 R506Q (factor V Leiden) mutationPRÜLLER, Florian; RAGGAM, Reinhard B; KOSTKA, Heike et al.British journal of haematology. 2013, Vol 163, Num 3, pp 414-417, issn 0007-1048, 4 p.Article

Platelet protein S directly inhibits procoagulant activity on platelets and microparticlesSTAVENUITER, Fabian; DAVIS, Nicole F; DUAN, Erning et al.Thrombosis and haemostasis. 2013, Vol 109, Num 2, pp 229-237, issn 0340-6245, 9 p.Article

Activated protein C up-regulates procoagulant tissue factor activity on endothelial cells by shedding the TFPI Kunitz 1 domainSCHUEPBACH, Reto A; VELEZ, Kara; RIEWALD, Matthias et al.Blood. 2011, Vol 117, Num 23, pp 6338-6346, issn 0006-4971, 9 p.Article

Cleavage at both Arg³⁰⁶ and Arg⁵⁰⁶ is required and sufficient for timely and efficient inactivation of factor Va by activated protein CBARHOOVER, Melissa A; KALAFATIS, Michael.Blood coagulation & fibrinolysis. 2011, Vol 22, Num 4, pp 317-324, issn 0957-5235, 8 p.Article

Activated Protein C Is Neuroprotective and Mediates New Blood Vessel Formation and Neurogenesis After Controlled Cortical Impact. CommentaryPETRAGLIA, Anthony L; MARKY, Andrew H; WALKER, Corey et al.Neurosurgery. 2010, Vol 66, Num 1, pp 165-172, issn 0148-396X, 8 p.Article

Activated Protein C and Diabetic NephropathyGILBERT, Richard E; MARSDEN, Philip A.The New England journal of medicine. 2008, Vol 358, Num 15, pp 1628-1630, issn 0028-4793, 3 p.Article

Activated protein C in sepsis : a critical reviewLEVI, Marcel.Current opinion in hematology. 2008, Vol 15, Num 5, pp 481-486, issn 1065-6251, 6 p.Article

Activated protein C in sepsis : the promise of nonanticoagulant activated protein CWEILER, Hartmut; RUF, Wolfram.Current opinion in hematology. 2008, Vol 15, Num 5, pp 487-493, issn 1065-6251, 7 p.Article

The functional significance of the autolysis loop in protein C and activated protein CLIKUIYANG; MANITHODY, Chandrashekhara; REZAIE, Alireza R et al.Thrombosis and haemostasis. 2005, Vol 94, Num 1, pp 60-68, issn 0340-6245, 9 p.Article

Regulation of inflammatory responses by activated protein C: the molecular mechanism(s) and therapeutic implicationsOKAJIMA, Kenji.Clinical chemistry and laboratory medicine. 2004, Vol 42, Num 2, pp 132-141, issn 1434-6621, 10 p.Article

Activation of endothelial cell protease activated receptor 1 by the protein C pathwayRIEWALD, Matthias; PETROVAN, Ramona J; DONNER, Aaron et al.Science (Washington, D.C.). 2002, Vol 296, Num 5574, pp 1880-1882, issn 0036-8075Article

C-reactive protein in febrile children 1 to 36 months of age with clinically undetectable serious bacterial infectionPULLIAM, Patrick N; ATTIA, Magdy W; CRONAN, Kathleen M et al.Pediatrics (Evanston). 2001, Vol 108, Num 6, pp 1275-1279, issn 0031-4005Article

Investigation of genotype-dependent differences in factor V activity as well as response to activated protein C by application of different methodsSIEGERT, G; KOSTKA, H; KUHLISCH, E et al.Blood coagulation & fibrinolysis. 2001, Vol 12, Num 8, pp 683-690, issn 0957-5235Article

Meconium peritonitis : Changes in fetal C-reactive protein and Ca 125 levels in relation to stage of diseaseOHMICHI, M; KANAI, H; KANZAKI, T et al.Journal of ultrasound in medicine. 1997, Vol 16, Num 4, pp 289-292, issn 0278-4297Article

Proposal for objective evaluation of the performance of various functional APC-resistance tests in genotyped patientsFREYBURGER, G; JAVORSCHI, S; LABROUCHE, S et al.Thrombosis and haemostasis. 1997, Vol 78, Num 5, pp 1360-1365, issn 0340-6245Article

Resistance to activated protein C, associated with oral contraceptives use ; Effect of formulations, duration of assumption, and doses of oestro-progestinsOLIVIERI, O; FRISO, S; CORROCHER, R et al.Contraception (Stoneham). 1996, Vol 54, Num 3, pp 149-152, issn 0010-7824Article

The interaction of protein S with the phospholipid surface is essential for the activated protein C-independent activity of protein SVAN WIJNEN, M; STAM, J. G; VAN'T VEER, C et al.Thrombosis and haemostasis. 1996, Vol 76, Num 3, pp 397-403, issn 0340-6245Article

Improved characteristics of aPC-resistance assay : Coatest aPC resistance by predilution of samples with factor V deficient plasmaKAPIOTIS, S; QUEHENBERGER, P; JILMA, B et al.American journal of clinical pathology. 1996, Vol 106, Num 5, pp 588-593, issn 0002-9173Article

Protease-activated receptor signalling by coagulation proteases in endothelial cells : Coagulation proteases and cardiovascular diseaseREZAIE, Alireza R.Thrombosis and haemostasis. 2014, Vol 112, Num 5, pp 876-882, issn 0340-6245, 7 p.Article